(Q34308653)

1 August 2017

1 reference

title

Fatigue in neurological disorders (English)

1 reference

1 August 2017

Abhijit Chaudhuri

1

1 reference

1 August 2017

Peter O Behan

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

1 August 2017

1 reference

1 August 2017

volume

363

1 reference

1 August 2017

issue

9413

1 reference

1 August 2017

page(s)

978-988

1 reference

1 August 2017

cites work

Fatigue and sarcoidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Treatments for fatigue in multiple sclerosis: a rapid and systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Paralytic vs. "nonparalytic" polio: distinction without a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Fatigue after stroke: a major but neglected issue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Venous oxygen levels during aerobic forearm exercise: An index of impaired oxidative metabolism in mitochondrial myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Cerebral metabolism is influenced by muscle ischaemia during exercise in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Word finding difficulty as a post-polio sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Fatigue and declines in cognitive functioning in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

The neuropsychology of post-polio fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Decreased capacity for mental effort after single supratentorial lacunar infarct may affect performance in everyday life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Cognitive functioning in patients with a small infarct in the brainstem.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Longitudinal assessment of neuropsychological functioning, psychiatric status, functional disability and employment status in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Orthostatic intolerance in adolescent chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Poststroke fatigue: a 2-year follow-up study of stroke patients in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Fatigue and basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Cognitive effects of unilateral posteroventral pallidotomy: a 4-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Parallels between post-polio fatigue and chronic fatigue syndrome: a common pathophysiology?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Hypothalamic dysfunction in overtrained athletes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

The neurobiology, diagnosis, and treatment of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Current status of cortisol findings in post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Protective and damaging effects of stress mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Pathophysiology of a central cause of post-polio fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Interventions for the treatment and management of chronic fatigue syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

A Double‐Blind, Placebo‐Controlled Trial of High‐Dose Prednisone for the Treatment of Post‐Poliomyelitis Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Fatigue in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Multiple sclerosis. Current concepts in management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Fatigue is not associated with raised inflammatory markers in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

An electrophysiological study of the mechanism of fatigue in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement--EEG evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Fatigue in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Diurnal effects of motor activity and fatigue in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Physiopathology and treatment of fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Total brain N-acetylaspartate: a new measure of disease load in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Relative increase in choline in the occipital cortex in chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Chronic fatigue syndrome in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Insights from mouse models of absence epilepsy into Ca2+ channel physiology and disease etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Neurology of ciguatera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Potassium channel antibodies in two patients with reversible limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Quadriceps muscle function and fatigue in women with Addison's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

A twin study of chronic fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Studying brain receptor function: a neuroendocrine approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Bromocriptine in the treatment of post-polio fatigue: a pilot study with implications for the pathophysiology of fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

A Double‐Blind, Placebo‐Controlled, Trial of Amantadine for the Treatment, of Fatigue in Patients with the, Post‐Polio Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Effect of exercise on stability of chronically enlarged motor units

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

Early and late losses of motor units after poliomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915794-2

7 January 2021

10.1016/S0140-6736(04)15794-2

Identifiers

DOI

1 reference

1 August 2017

1 reference